London
21 °C
Manchester
Glasgow
16 °C
Dublin
Belfast
Washington
Denver
21 °C
Atlanta
Dallas
28 °C
Houston Texas
25 °C
New Orleans
El Paso
Phoenix
Los Angeles
21 °C
12 °C
30 °C
23 °C
12 °C
Featured
Last news
British 'Netflix' conman gets six-year prison term in France
A convicted British conman who featured in a Netflix documentary was sentenced on Thursday to six years in prison by a French court for running over and injuring two police officers while trying to escape.
Swindling Brit stands trial for injuring French police in getaway
A convicted British conman who featured in a Netflix documentary appeared in a French court on Thursday charged with knocking over and injuring two police officers in 2022 as he tried to escape from them.
Swedish police say 'multiple nationalities' died in mass shooting
Swedish police said Thursday the victims of the country's worst mass shooting were of multiple nationalities, as Syria and Bosnia said their citizens were among the dead.
Hermoso 'overwhelmed' by forced kiss, teammates tell trial
Jenni Hermoso was "overwhelmed" by former Spanish football boss Luis Rubiales' forced kiss and was unable to enjoy winning the Women's World Cup, her teammates told a court Thursday.
'Life or death consequences for millions': NGOs stunned by US aid freeze
The freeze in aid funding by Donald Trump's new US administration has left humanitarian workers seeing a large proportion of their budget cut off and fearing millions will be affected as programmes are suspended.
Chelsea star Kerr denies using 'whiteness as an insult' against police
Chelsea and Australia striker Sam Kerr told a court Thursday she did not use "whiteness as an insult" in a heated exchange with police during which she called one officer "stupid and white".
Decathlon on back foot over China forced labour accusations
French company Decathlon, the world's biggest sports equipment retailer, on Thursday defended its human rights record after reports it had benefited from forced labour in China.
Swedish police say mass shooting scene resembled 'inferno'
Swedish police said Thursday they met a scene resembling "an inferno" when they arrived at the scene of country's worst mass shooting that left 10 dead plus the gunman.
UK to quicken rollout of mini-nuclear reactors
Britain's Labour government on Thursday said changes to planning laws will speed up the country's rollout of mini-nuclear reactors aimed at providing cheaper and cleaner energy.
'Multiple nationalities' among victims in Swedish mass shooting: police
Swedish police said Thursday that there were "multiple nationalities" among the victims in the country's worst mass shooting that left 10 dead plus the gunman.
Top South Korean officer says was asked to help Yoon martial law bid
The commander of a crack South Korean special forces unit told a court Thursday he had been asked by a superior officer how to cut electricity to parliament during last year's failed martial law order by impeached president Yook Suk Yeol.
Colombian president says cocaine 'no worse than whisky'
Cocaine "is no worse than whisky" and is only illegal because it comes from Latin America, said Colombian President Gustavo Petro during a live broadcast of a government meeting.
Turkey marks second anniversary of quake disaster
Turkey on Thursday commemorates the second anniversary of the February 6, 2023 earthquake, which claimed nearly 60,000 lives including in neighbouring Syria and turned entire cities into ruins.
India's sacred boat service for giant Hindu festival
For millions of Hindu pilgrims at India's millennia-old vast Kumbh Mela festival, the culmination of their journey is ritual bathing in the holy waters where sacred rivers meet.
Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
VANCOUVER, BC / ACCESS Newswire / February 6, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, Inka Health Corp. ("Inka Health") has entered into an Expression of Interest (EOI) with Quantify Research ("Quantify"), a leading global provider of healthcare data analytics and real-world evidence solutions. This EOI establishes a framework for potential collaboration between the two entities to explore synergies in advanced data analytics and oncology research, with a particular focus on leveraging AI-driven predictive modelling to enhance cancer treatment insights.
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ADHD and schizophrenia, with 1-2 additional IND applications filed in late 2025/early 2026
EQ Works Secures $1.45 Million Engagement with Leading Automotive Brand
TORONTO, ON / ACCESS Newswire / February 6, 2025 / EQ Inc. (TSXV:EQ) ("EQ Works" or the "Company"), a leader in data-driven marketing and insights, is pleased to announce a new $1.45 million engagement with one of Canada's leading automotive brands. This partnership will combine EQ Works' AI driven proprietary data and insights with its targeting technology platform to enhance customer engagement and drive acquisition for the brand.
Bausch Health Provides Update on Strategic Alternatives
LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following update on a potential sale of its subsidiary, Bausch + Lomb Corporation (NYSE:BLCO)(TSX:BLCO), which was disclosed in December 2024 following a regulatory request:
KALEO Frontman JJ Julius Son and Entrepreneur Robert Wessman to Launch Unique Limited-Edition Wine Collection at WineParis
An Icelandic Merger of Music and Winemaking
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform
US Marine vet acquitted in NY subway death joins tech firm
A US Marine veteran who was acquitted in the chokehold death of a homeless man on the New York subway -- a high-profile case highlighting the divisive issue of race in America -- has been hired by a major Silicon Valley firm allied with Donald Trump.
Sweden mourns after school massacre
Sweden on Wednesday mourned the victims of its worst mass killing as police indicated that the gunman likely shot himself after killing 10 people at an adult education centre.
Chelsea star Kerr says treated differently because of 'skin colour'
Chelsea striker Sam Kerr Wednesday told a court she was treated differently by police "because of the colour of my skin" after "fearing for my life" following an incident with a taxi driver.
Swedish king leads mourning after school massacre
Sweden on Wednesday mourned the victims of its worst mass killing as police indicated that the gunman likely shot himself after killing 10 people at an adult education centre.
Chelsea star Kerr 'feared for my life' during taxi ride
Chelsea striker Sam Kerr said she "feared for my life" while she and her partner were in the back of a taxi moments before one of them smashed the vehicle's rear window.
Swedish police say school killing spree gunman likely shot himself
Swedish police indicated Wednesday that a gunman who slaughtered 10 people at an adult education centre shot himself as the country mourned its worst mass killing.
Sweden reels from worst mass shooting in its history
Sweden on Wednesday was recovering from the deadliest mass shooting in its history after 10 people -- as well as the suspected gunman -- were killed at an education centre in the city of Orebro, with many questions still unanswered.
Blackbox Press Event and Regional Government Roundtable
It being our first event, we began by explaining Blackbox's mission statement and the social context that led to our launch. General Manager Taiki Iwasaki talked about the growing support for startups - especially foreign startups - in Japan over the last few years.
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025
DENVER, CO / ACCESS Newswire / February 5, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its second quarter of fiscal 2025, after the market close on Wednesday, February 12, 2025. The Company has scheduled a conference call and webcast that same day, Wednesday, February 12, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.
The Icon in Culinary Arts - Chef Alan Coxon, Challanges the Stigma Surrounding the Taste of Collagen Peptides
Chef Alan Coxon, an Icon in the Culinary Arts, Sets a New Standard by Partnering With Enchant Brands, an Innovator in Nutrition Powders, to Challenge and Redefine the Stigma Surrounding the Taste of Collagen Peptides.
Polaris Renewable Energy Declares Quarterly Dividend
TORONTO, ON / ACCESS Newswire / February 5, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding.
CTT Pharma Adds Independent Director With NIH/NSF Experience
TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.D. in Pathology from the University of Maryland School of Medicine. Following her Ph.D. she spent 3 years at the National Cancer Institute(NCI) at the National Institutes of Health(NIH) where she spent her time focused on anti-cancer mechanisms of novel chemotherapeutic compounds. From there Dr. Cole worked at four different universities as a Biomedical scientist, professor, and eventually as a vice Provost and Dean. She has published twenty-two peer reviewed papers and has been granted two patents related to a human liver cell line. Dr. Cole has been awarded many notable grants including grants from the National Science Foundation(NSF) and the Howard Hughes Medical Institute. Dr. Cole's professional development as a scientist, an educator and a university-level administrator has provided her with a distinct scientific perspective and an ability to critically analyze meaningful data and research design. Her Ph.D. in Pathology from the University of Maryland School of Medicine and postdoctoral experience at the NIH/NCI in cancer research have positioned her well to not only understand the science behind this technology, but the impact from a human pathological perspective. CTT is honored to have Dr. Cole on our team and looks forward to her contributions.